Share this article
Share this article
ResearchAndMarkets.com's offering.
The global analgesics market is expected to grow from $68.2 billion in 2019 to $78.1 billion in 2020 at a compound annual growth rate (CAGR) of 14.7%.
This growth is mainly due to the COVID-19 outbreak and the neuroinvasive nature of the virus. The CNS is more prone to the viral infection. The virus affects the senses of smell and taste and therefore it is important to curb the interaction between the viral protein and the human receptor, and this factor is driving the demand for CNS drugs. The market is then expected to grow at a CAGR of 5.5% from 2021 and reach $91 billion in 2023.